Eli Lilly Corp. buy BiotechBee
Start price
07.09.22
/
70%
€312.95
Target price
31.12.25
€450.00
Performance (%)
24.24%
End price
05.05.23
€388.80
Summary
This prediction ended on 05.05.23 with a price of €388.80. The BUY prediction by BiotechBee finished with a performance of 24.24%. A total of €2.00 was paid as dividends for this prediction. BiotechBee has 70% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Eli Lilly Corp. | 0.543% | 0.543% | 90.651% |
| iShares Core DAX® | 2.594% | -1.861% | 13.242% |
| iShares Nasdaq 100 | 3.553% | -2.064% | 38.293% |
| iShares Nikkei 225® | 0.687% | -8.704% | 17.510% |
| iShares S&P 500 | 2.209% | -1.988% | 27.632% |
According to BiotechBee what are the pros and cons of Eli Lilly Corp. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Eli Lilly Corp. diskutieren
Buy mit Kursziel 450,0
In the thread Trading Eli Lilly Corp.
Stopped prediction by BiotechBee for Eli Lilly Corp.
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€422.40
27.06.23
27.06.23
€800.00
31.01.29
31.01.29
20.50%
01.10.23
01.10.23
Could be very worthwhile Investment >20% year
